- call +1-201-465-4211
- email sales@mrinsights.biz
Insulin lispro is synthetic insulin with a very rapid onset and short duration of action. Diabetic patients typically use it immediately before meals to prevent postprandial hyperglycemia. Its absorption is more rapid than regular insulin. It is made by reversing the amino acids lysine and proline in the beta chain of the insulin polypeptide.
Scope of the Report:
This report focuses on the Insulin Lispro in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The technical barriers of insulin lispro are high, and the core technology of insulin lispro concentrates in relative large companies including Eli Lilly and Company, Gan & Lee Pharmaceuticals. There are no enterprises in India producing insulin lispro. Biocon, the local enterprise, are in the stage of R&D stage to produce insulin lispro.
India import insulin lipsro products to meet local patients’ needs and India import products from Eli Lilly. Gan & Lee products are almost used by local patients in China, where has the largest number diabetes patients in the world.
The worldwide market for Insulin Lispro is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Eli Lilly and Company
Gan & Lee Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Rapid-acting insulin
Short-acting insulin
Intermediate-acting insulin
Long-acting insulin
Market Segment by Applications, can be divided into
Type 1 Diabetes
Type 2 Diabetes
There are 15 Chapters to deeply display the global Insulin Lispro market.
Chapter 1, to describe Insulin Lispro Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Insulin Lispro, with sales, revenue, and price of Insulin Lispro, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Insulin Lispro, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Insulin Lispro market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Insulin Lispro sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Insulin Lispro Introduction
1.2 Market Analysis by Type
1.2.1 Rapid-acting insulin
1.2.2 Short-acting insulin
1.2.3 Intermediate-acting insulin
1.2.4 Long-acting insulin
1.3 Market Analysis by Applications
1.3.1 Type 1 Diabetes
1.3.2 Type 2 Diabetes
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Eli Lilly and Company
2.1.1 Business Overview
2.1.2 Insulin Lispro Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eli Lilly and Company Insulin Lispro Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Gan & Lee Pharmaceuticals
2.2.1 Business Overview
2.2.2 Insulin Lispro Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Gan & Lee Pharmaceuticals Insulin Lispro Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Insulin Lispro Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Insulin Lispro Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Insulin Lispro Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Insulin Lispro Manufacturer Market Share in 2017
3.3.2 Top 6 Insulin Lispro Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Insulin Lispro Market Analysis by Regions
4.1 Global Insulin Lispro Sales, Revenue and Market Share by Regions
4.1.1 Global Insulin Lispro Sales and Market Share by Regions (2013-2018)
4.1.2 Global Insulin Lispro Revenue and Market Share by Regions (2013-2018)
4.2 North America Insulin Lispro Sales and Growth Rate (2013-2018)
4.3 Europe Insulin Lispro Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Insulin Lispro Sales and Growth Rate (2013-2018)
4.5 South America Insulin Lispro Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Insulin Lispro Sales and Growth Rate (2013-2018)
5 North America Insulin Lispro by Countries
5.1 North America Insulin Lispro Sales, Revenue and Market Share by Countries
5.1.1 North America Insulin Lispro Sales and Market Share by Countries (2013-2018)
5.1.2 North America Insulin Lispro Revenue and Market Share by Countries (2013-2018)
5.2 United States Insulin Lispro Sales and Growth Rate (2013-2018)
5.3 Canada Insulin Lispro Sales and Growth Rate (2013-2018)
5.4 Mexico Insulin Lispro Sales and Growth Rate (2013-2018)
6 Europe Insulin Lispro by Countries
6.1 Europe Insulin Lispro Sales, Revenue and Market Share by Countries
6.1.1 Europe Insulin Lispro Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Insulin Lispro Revenue and Market Share by Countries (2013-2018)
6.2 Germany Insulin Lispro Sales and Growth Rate (2013-2018)
6.3 UK Insulin Lispro Sales and Growth Rate (2013-2018)
6.4 France Insulin Lispro Sales and Growth Rate (2013-2018)
6.5 Russia Insulin Lispro Sales and Growth Rate (2013-2018)
6.6 Italy Insulin Lispro Sales and Growth Rate (2013-2018)
7 Asia-Pacific Insulin Lispro by Countries
7.1 Asia-Pacific Insulin Lispro Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Insulin Lispro Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Insulin Lispro Revenue and Market Share by Countries (2013-2018)
7.2 China Insulin Lispro Sales and Growth Rate (2013-2018)
7.3 Japan Insulin Lispro Sales and Growth Rate (2013-2018)
7.4 Korea Insulin Lispro Sales and Growth Rate (2013-2018)
7.5 India Insulin Lispro Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Insulin Lispro Sales and Growth Rate (2013-2018)
8 South America Insulin Lispro by Countries
8.1 South America Insulin Lispro Sales, Revenue and Market Share by Countries
8.1.1 South America Insulin Lispro Sales and Market Share by Countries (2013-2018)
8.1.2 South America Insulin Lispro Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Insulin Lispro Sales and Growth Rate (2013-2018)
8.3 Argentina Insulin Lispro Sales and Growth Rate (2013-2018)
8.4 Colombia Insulin Lispro Sales and Growth Rate (2013-2018)
9 Middle East and Africa Insulin Lispro by Countries
9.1 Middle East and Africa Insulin Lispro Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Insulin Lispro Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Insulin Lispro Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Insulin Lispro Sales and Growth Rate (2013-2018)
9.3 UAE Insulin Lispro Sales and Growth Rate (2013-2018)
9.4 Egypt Insulin Lispro Sales and Growth Rate (2013-2018)
9.5 Nigeria Insulin Lispro Sales and Growth Rate (2013-2018)
9.6 South Africa Insulin Lispro Sales and Growth Rate (2013-2018)
10 Global Insulin Lispro Market Segment by Type
10.1 Global Insulin Lispro Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Insulin Lispro Sales and Market Share by Type (2013-2018)
10.1.2 Global Insulin Lispro Revenue and Market Share by Type (2013-2018)
10.2 Rapid-acting insulin Sales Growth and Price
10.2.1 Global Rapid-acting insulin Sales Growth (2013-2018)
10.2.2 Global Rapid-acting insulin Price (2013-2018)
10.3 Short-acting insulin Sales Growth and Price
10.3.1 Global Short-acting insulin Sales Growth (2013-2018)
10.3.2 Global Short-acting insulin Price (2013-2018)
10.4 Intermediate-acting insulin Sales Growth and Price
10.4.1 Global Intermediate-acting insulin Sales Growth (2013-2018)
10.4.2 Global Intermediate-acting insulin Price (2013-2018)
10.5 Long-acting insulin Sales Growth and Price
10.5.1 Global Long-acting insulin Sales Growth (2013-2018)
10.5.2 Global Long-acting insulin Price (2013-2018)
11 Global Insulin Lispro Market Segment by Application
11.1 Global Insulin Lispro Sales Market Share by Application (2013-2018)
11.2 Type 1 Diabetes Sales Growth (2013-2018)
11.3 Type 2 Diabetes Sales Growth (2013-2018)
12 Insulin Lispro Market Forecast (2018-2023)
12.1 Global Insulin Lispro Sales, Revenue and Growth Rate (2018-2023)
12.2 Insulin Lispro Market Forecast by Regions (2018-2023)
12.2.1 North America Insulin Lispro Market Forecast (2018-2023)
12.2.2 Europe Insulin Lispro Market Forecast (2018-2023)
12.2.3 Asia-Pacific Insulin Lispro Market Forecast (2018-2023)
12.2.4 South America Insulin Lispro Market Forecast (2018-2023)
12.2.5 Middle East and Africa Insulin Lispro Market Forecast (2018-2023)
12.3 Insulin Lispro Market Forecast by Type (2018-2023)
12.3.1 Global Insulin Lispro Sales Forecast by Type (2018-2023)
12.3.2 Global Insulin Lispro Market Share Forecast by Type (2018-2023)
12.4 Insulin Lispro Market Forecast by Application (2018-2023)
12.4.1 Global Insulin Lispro Sales Forecast by Application (2018-2023)
12.4.2 Global Insulin Lispro Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Insulin Lispro Picture
Table Product Specifications of Insulin Lispro
Figure Global Sales Market Share of Insulin Lispro by Types in 2017
Table Insulin
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
